- Home
- PRDO vs IRON Comparison
PRDO vs IRON Comparison
Compare PRDO & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRDO
- IRON
- Stock Information
- Founded
- PRDO 1994
- IRON 2017
- Country
- PRDO United States
- IRON United States
- Employees
- PRDO N/A
- IRON N/A
- Industry
- PRDO Other Consumer Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- PRDO Real Estate
- IRON Health Care
- Exchange
- PRDO Nasdaq
- IRON Nasdaq
- Market Cap
- PRDO 2.3B
- IRON 2.1B
- IPO Year
- PRDO N/A
- IRON N/A
- Fundamental
- Price
- PRDO $36.72
- IRON $87.23
- Analyst Decision
- PRDO Buy
- IRON Strong Buy
- Analyst Count
- PRDO 1
- IRON 13
- Target Price
- PRDO $42.00
- IRON $102.23
- AVG Volume (30 Days)
- PRDO 397.6K
- IRON 623.6K
- Earning Date
- PRDO 11-04-2025
- IRON 11-11-2025
- Dividend Yield
- PRDO 1.63%
- IRON N/A
- EPS Growth
- PRDO 12.96
- IRON N/A
- EPS
- PRDO 2.30
- IRON N/A
- Revenue
- PRDO $768,844,000.00
- IRON N/A
- Revenue This Year
- PRDO $25.27
- IRON N/A
- Revenue Next Year
- PRDO $4.01
- IRON N/A
- P/E Ratio
- PRDO $16.04
- IRON N/A
- Revenue Growth
- PRDO 15.99
- IRON N/A
- 52 Week Low
- PRDO $20.97
- IRON $30.82
- 52 Week High
- PRDO $38.03
- IRON $95.95
- Technical
- Relative Strength Index (RSI)
- PRDO 61.70
- IRON 70.58
- Support Level
- PRDO $34.55
- IRON $83.52
- Resistance Level
- PRDO $37.15
- IRON $89.00
- Average True Range (ATR)
- PRDO 0.75
- IRON 3.75
- MACD
- PRDO 0.09
- IRON 0.93
- Stochastic Oscillator
- PRDO 84.84
- IRON 69.65
About PRDO Perdoceo Education Corporation
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.